Hemostemix Inc (HEM.V) has seen a remarkable surge, gaining over 8% in just one trading day.
In the latest trading session, Hemostemix Inc stock soared by 8.33%, closing at CA$0.07. This impressive uptick comes amid ongoing developments for the company, signaling potential investor confidence in its future prospects.
Advertisement
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeAdvertisement
Market cap
$13.32M
52W high
$0.14
52W low
$0.04
1W change
+15.38%
Beta
0.61
Analyst Price Targets
Based on analyst covering HEM
Wall Street analysts forecast HEM stock price to rise 1180.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1180.0% Upside
Current Price
C$0.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
140.1%
Annualized
90-Day Vol
116.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.08 | C$0.05 – C$0.13 |
| 60 trading days | C$0.08 | C$0.04 – C$0.17 |
| 90 trading days | C$0.09 | C$0.04 – C$0.21 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider the recent performance of Hemostemix Inc as a sign of growing interest, but remain cautious about the inherent risks associated with small-cap stocks.
Hemostemix Inc Surges 8.33% in One Day
With a market cap of CA$12.3 million, Hemostemix Inc's stock performance highlights the potential for rapid price movements in small-cap stocks.
Bull case
The recent price increase shows positive market sentiment. Investors might be excited about future developments and the company’s strategic moves in the stem cell therapy sector.
Bear case
Despite the recent gains, Hemostemix Inc is still a small-cap stock with limited coverage and high volatility. This can pose risks for investors.
Advertisement
Market Reaction to Hemostemix Inc
The recent surge in Hemostemix Inc's stock price indicates a positive market reaction, likely fueled by investor optimism regarding the company's strategic initiatives. As Hemostemix continues to engage in significant developments within the stem cell therapy field, this uptick may reflect growing confidence in its future prospects.
Understanding the Small-Cap Landscape
Investing in small-cap stocks like Hemostemix Inc can offer substantial growth potential, but it also comes with heightened risks. With a market cap of approximately CA$12.3 million, investors should be aware of the volatility and limited coverage associated with such companies. It's crucial to conduct thorough research and consider both the opportunities and challenges before investing.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
